Sonteg Pharmaceuticals Private Limited
Pharmaceutical company manufacturing, importing, and exporting drugs, enzymes, vitamins, and herbals since 1995.
1995 | Mumbai, Maharashtra (India) | Active
Sonteg Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.62 M
- Company Age 29 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 0.63%
About Sonteg Pharmaceuticals
Sonteg Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 August 1995 and has a history of 29 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.62 M, as per Ministry of Corporate Affairs (MCA) records.
Labhubhai Lathia, Chandubhai Ratanpara, Dineshkumar Karad, and One other member serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232MH1995PTC091642
- Company No.
091642
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Sonteg Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Labhubhai Lathia  | Director | 15-Jul-2021 | Current |
| Chandubhai Ratanpara | Director | 15-Jul-2021 | Current |
| Dineshkumar Karad | Director | 15-Jul-2021 | Current |
| Jinesh Patel | Director | 15-Jul-2021 | Current |
Financial Performance of Sonteg Pharmaceuticals.
Sonteg Pharmaceuticals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sonteg Pharmaceuticals?
In 2021, Sonteg Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Jivan Fabrics Private Limited
Labhubhai Lathia is a mutual person
- Mercury Business Centre Private Limited
Chandubhai Ratanpara is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sonteg Pharmaceuticals?
Unlock and access historical data on people associated with Sonteg Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sonteg Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sonteg Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
